Intercell expects regulatory decisions on Japanese encephalitis vaccine soon
The Austrian vaccine producer, Intercell AG, said that regulatory decisions should be forthcoming soon on its applications to market a new prophylactic vaccine against Japanese encephalitis, IC51. Japanese encephalitis is a virulent mosquito-borne infection that is a leading cause of childhood encephalitis and viral encephalitis in Asia.
18 August 2008